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Biosynthesis of angelyl-CoA 
in Saccharomyces cerevisiae
Roberta Callari1,2, David Fischer1, Harald Heider1 and Nora Weber1*
Abstract 
Background: The angelic acid moiety represents an essential modification in many biologically active products. 
These products are commonly known as angelates and several studies have demonstrated their therapeutic benefits, 
including anti-inflammatory and anti-cancer effects. However, their availability for use in the development of thera-
peutics is limited due to poor extraction yields. Chemical synthesis has been achieved but its complexity prevents 
application, therefore microbial production may offer a promising alternative. Here, we engineered the budding yeast 
Saccharomyces cerevisiae to produce angelyl-CoA, the CoA-activated form of angelic acid.
Results: For yeast-based production of angelyl-CoA we first expressed genes recently identified in the biosynthetic 
cluster ssf of Streptomyces sp. SF2575 in S. cerevisiae. Exogenous feeding of propionate and heterologous expression 
of a propionyl-CoA synthase from Streptomyces sp. were initially employed to increase the intracellular propionyl-CoA 
level, resulting in production of angelyl-CoA in the order of 5 mg/L. Substituting the Streptomyces sp. propionyl-CoA 
carboxylase with a carboxylase derived from Streptomyces coelicolor resulted in angelyl-CoA levels up to 6.4 mg/L. 
In vivo analysis allowed identification of important intermediates in the pathway, including methyl-malonyl-CoA and 
3-hydroxyl-2-methyl-butyryl-CoA. Furthermore, methyl-malonate supplementation and expression of matB CoA ligase 
from S. coelicolor allowed for methyl-malonyl-CoA synthesis and supported, together with parts of the ssf pathway, 
angelyl-CoA titres of approximately 1.5 mg/L. Finally, feeding of angelic acid to yeasts expressing acyl-CoA ligases 
from plant species led to angelyl-CoA production rates of approximately 40 mg/L.
Conclusions: Our results demonstrate the biosynthesis of angelyl-CoA in yeast from exogenously supplied carbox-
ylic acid precursors. This is the first report on the activity of the ssf genes. We envision that our approach will provide a 
platform for a more sustainable production of the pharmaceutically important compound class of angelates.
Keywords: Angelyl-CoA, Angelate, Propionyl-CoA, Methylmalonyl-CoA, 2-Methylacetoacetyl-CoA, 3-Hydroxyl-2-
methyl-butyryl-CoA, Metabolic engineering, CoA-ligase, Euphorbia peplus, Yeast
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Background
Esters of angelic acid ((Z)-2-methyl-2-butenoic acid), also 
known as angelates, are pharmacologically active natural 
products widely distributed in plants (Additional file  1: 
Figure S1). The best-known and most studied exam-
ple is certainly represented by ingenol-3-angelate (also 
known as ingenol-mebutate), a topical chemotherapeutic 
recently approved by the FDA for the treatment of actinic 
keratosis, a pre-cancerous skin condition. This ester of 
the diterpenoid ingenol and angelic acid is derived from 
the sap of Euphorbia peplus—the garden weed “petty 
spurge”, known as a traditional remedy for warts and basal 
cell carcinomas [1]. Other notable plant angelates include 
petasin and its isomers isopetasin and neopetasin, found 
in Petasites hybridus, a species used for years as herbal 
supplement for its anti-spasmodic and anti-inflamma-
tory effects [2]. The cytotoxic gordonosides, angelic acid 
esters isolated from Gordonia chrysandra, are frequently 
applied in traditional medicine for treating diarrhea, gas-
tralgia, and arthritis [3]. Decoursinol angelate, isolated 
from roots of the medicinal herb Angelica gigas Nakai, 
exerts anti-cancer and anti-inflammatory activities [4]. 
Thapsigargin, found in the roots of the mediterranean 
plant species Thapsia garganica L., is an inhibitor of the 
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sarco-endoplasmic reticulum  Ca2+-ATPase used in the 
treatment of solid tumors [5].
Recently, bacterial angelates have also been reported: 
SF2575 is a tetracycline polyketide-angelic acid ester pro-
duced by Streptomyces sp. SF2575 [6]. The compound 
exhibits not only weak antibiotic activity but also potent 
anti-cancer activity towards a broad range of cancer cell 
lines [7]. Trehangelins are trehalose angelates produced 
by the endophytic actinomycete Polymorphospora rubra 
K07-0510, displaying potent inhibitory activity against 
hemolysis of red blood cells [8].
Supply of angelates is currently based on extraction of 
the pure compounds from the species of origin. In some 
cases chemical synthesis has also been achieved [9–12]. 
However, both approaches are low yielding and have high 
environmental impact. In the case of ingenol-mebutate, 
direct isolation from the aerial tissue of E. peplus only 
yields 1.1  mg/kg of tissue [13]. Semi-synthesis, start-
ing from the more abundant cognate compound inge-
nol, obtained an overall yield of around 31%, but relied 
on expensive catalysts [10]. Thapsigargin is isolated from 
wild plants of T. garganica, where it is present in minute 
amounts (1.2–1.5% of the dry weight, depending on the 
selected tissue) [5]. Its total synthesis in 42 steps from 
(S)-carvone had an overall yield of only 0.6% [9].
To make these compounds more accessible, microbial 
production certainly represents an interesting alternative 
route.
Unfortunately, biosynthesis of any of the plant ange-
lates has not yet been elucidated and even the enzymes 
involved in the biosynthesis of the angelic acid moiety 
are unknown. In contrast, the gene clusters responsi-
ble for the bacterial synthesis of SF2575 (“ssf”) and tre-
hangelin A (“thg”) have been identified and characterized 
[6, 14]. This has led to the elucidation of the metabolic 
pathways responsible for the biosynthesis of these com-
pounds and the identification of enzymes needed for 
assembly of their core structures and also for tailoring 
reactions, including angelyl-CoA (AN-CoA) formation 
and esterification. The latter is synthesized in both Strep-
tomyces sp. SF2575 and P. rubra by enzymes resembling 
those found in fatty acid biosynthesis. In joint action, the 
identified beta-ketoacyl-(acyl-carrier-protein) synthase 
III (KAS III), the 3-ketoacyl-(acyl-carrier-protein) reduc-
tase and the enoyl-CoA hydratase may lead to AN-CoA 
biosynthesis starting from acetyl-CoA (Ac-CoA) and 
methyl-malonyl-CoA (MM-CoA) via the intermediates 
2-methyl-acetoacetyl-CoA (MAA-CoA) and 3-hydroxyl-
2-methyl-butyryl-CoA (HMB-CoA) (Fig. 1). The enzymes 
from P. rubra were characterized in  vitro [14], whereas 
the enzymes from S. sp. SF2575 have been suggested to 
be involved in AN-CoA formation based on homology to 
functionally similar enzymes from other species [6]. Pick-
ens and co-workers [6] proposed that in S. sp. SF2575 
condensation of MM-CoA and Ac-CoA to MMA-CoA is 
catalyzed by SsfN, a KAS III homolog. SsfK, homologous 
to 3-oxoacyl-ACP reductases, enables keto-reduction of 
MAA-CoA yielding HMB-CoA. In the last step, stereo-
specific dehydration of HMB-CoA by SsfJ (a member of 
the enoyl-CoA hydratase/isomerase family) results in 
AN-CoA. Moreover, SsfE, homologous to biotin-depend-
ent methyl-malonyl-CoA decarboxylases and propio-
nyl-CoA carboxylases, was suggested to be involved in 
MM-CoA formation from Pr-CoA.
In this study we describe production of angelyl-CoA 
in the yeast Saccharomyces cerevisiae. This production 
host has well-established advantages when compared to 
other microorganisms such as robustness and resistance 
under harsh industrial conditions, resistance to phages 
and the ability to ferment sugars under acidic conditions. 
AN-CoA biosynthesis was achieved through expres-
sion of a heterologous pathway derived from the bacte-
rial ssf cluster, allowing AN-CoA synthesis starting from 
propionyl-CoA. Upon engineering of the propionyl-CoA 
metabolism we reached maximum titres of approxi-
mately 6.4 mg/L AN-CoA. Moreover, the identification of 
Fig. 1 Bacterial biosynthetic pathway from MM-CoA to AN-CoA. MM-CoA—methylmalonyl-CoA; Ac-CoA—acetyl-CoA; MAA-CoA—
2-methyl-acetoacetyl-CoA; HMB-CoA—3-hydroxyl-2-methyl-butyryl-CoA; AN-CoA—angelyl-CoA; KAS III—beta-ketoacyl-(acyl-carrier-protein) 
synthase III; 3-ketoacyl-ACP-reductase—3-ketoacyl-(acyl-carrier-protein) reductase
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acyl-CoA synthases from different plant sources enabled 
the use of angelic acid as substrate, yielding AN-CoA in 
titres of approximately 40 mg/L.
AN-CoA represents an important building block for 
the synthesis of many plant secondary metabolites with 
biological activity. AN-CoA is the substrate used by acyl-
CoA transferases to catalyse esterification reactions, add-
ing the angelate moiety onto diverse acceptor molecules. 
Its biosynthesis in yeast will enable angelyl-acylation of 
a broad range of compounds. Although further optimi-
zation is needed, we anticipate that the strains reported 
here will pave the way for the bio-based production of 
esters of angelic acid.
Results
Angelyl‑CoA production in yeast starting from propionate
Based on the hypotheses of Pickens et al. [6] we assem-
bled the pathway to AN-CoA biosynthesis in baker’s 
yeast. First, we expressed the bacterial genes ssfE, ssfN, 
ssfK, and ssfJ as yeast codon-optimized versions for the 
conversion of Pr-CoA into AN-CoA (Fig. 2a). Pr-CoA is 
an intermediate metabolite produced in yeast through 
a variety of pathways including thio-esterification of 
propionate and catabolism of odd chain fatty acids and 
selected amino acids [15]. A plasmid, co-expressing the 
four heterologous genes under control of strong constitu-
tive promoters was constructed together with a control 
plasmid (no ORFs downstream of the promoters). Trans-
formation into yeast generated strains ANG1 (control) 
and ANG2 (ssfE/ssfN/ssfK/ssfJ). These strains were tested 
for production of AN-CoA. In strain ANG2 around 
0.37  mg/L of AN-CoA accumulated, whereas no AN-
CoA could be detected in strain ANG1 (control strain, 
data not shown).
To test whether an improved precursor supply may 
increase AN-CoA synthesis, we cultured the strains in 
propionic acid-supplemented medium. Propionic acid 
is metabolized by the yeast via activation to Pr-CoA, 
which is catalyzed by ACS1—an endogenous isoenzyme 
of acetyl-CoA synthase [16]. ACS1 can accept propionic 
acid as substrate, albeit at lower rates than acetic acid 
[17]. To further improve propionate thio-esterification, 
we then expressed an acyl-CoA synthase specific for 
this anion. We chose to express propionyl-CoA syn-
thase prpE from Salmonella enterica serovar Typhimu-
rium, encoding an enzyme required for the catabolism 
of propionate in this bacterium [18]. Two strains were 
generated, one expressing the ssf genes and an empty 
plasmid (ANG3), the other one expressing the ssf genes 
together with prpE under control of the PGK1 promoter 
(ANG4). Feeding with propionic acid led to 5.5-fold 
elevated intracellular accumulation of Pr-CoA in strain 
ANG3, compared to the non-fed strain (Fig.  2b). Upon 
propionate supplementation, prpE expression in strain 
ANG4 boosted Pr-CoA accumulation to 20-fold higher 
values than those seen with strain ANG3 not express-
ing prpE (Fig.  2b). This is in accordance with an earlier 
report on prpE expression in the presence of exogenous 
propionate, leading to substantial accumulation of Pr-
CoA in yeast [19]. The elevated concentration of Pr-CoA 
inside the cells resulted in a massive increase in AN-CoA 
production (from 0.37 mg/L to almost 5 mg/L at 12 h of 
growth, see Fig. 3a) but it also affected cell growth. The 
increased energy requirements needed to maintain cyto-
solic pH homeostasis in the presence of propionic acid in 
the medium may, in addition, contribute to growth retar-
dation [20]. We cultured the cells in medium buffered to 
pH 4.5 as this pH value is a compromise between support 
of a decent yeast growth and remaining below the  pKa of 
propionic acid  (pKa = 4.88). This pH supports passive dif-
fusion of propionic acid into the cells [21]. Cells cultured 
at pH 4.5 showed better growth and a slightly elevated 
production of AN-CoA (Fig. 2c).
We then performed time course experiments with 
strain ANG4 (prpE + ssfE/ssfN/ssfK/ssfJ; Fig.  3a) and a 
newly constructed strain, ANG5 (prpE + pccB/accA1/
ssfN/ssfK/ssfJ; Fig.  3b). The latter strain expresses the 
propionyl-CoA carboxylase complex from Streptomy-
ces coelicolor [22], instead of ssfE. The complex consists 
of the transcarboxylase subunit PccB and the biotin car-
rier protein/biotin carboxylase subunit AccA1 (PccB/
AccA1 complex). Both strains were grown in buffered, 
propionate-supplemented medium. AN-CoA forma-
tion peaked at 12  h, but could barely be detected after 
48  h of culture. AN-CoA accumulation reached maxi-
mally 4.9 ± 0.5 mg/L in strain ANG4 (Fig. 3a), whereas it 
climbed to even 6.4 ± 0.2 mg/L in strain ANG5 after 12 h 
of growth (Fig.  3b). Similar dynamics were detected for 
Ac-CoA, a critical metabolite for growth and prolifera-
tion. Ac-CoA accumulation also peaked at 12 h and went 
down to almost 0 upon 96  h of shake flask culture. In 
order to correlate AN-CoA production with Pr-CoA pro-
duction, we also analyzed the relative amount of Pr-CoA 
accumulation in strains ANG4 and ANG5. Both strains 
accumulated similar levels of Pr-CoA within the first 
12  h. Thereafter, in strains expressing pccB/accA1, Pr-
CoA remained stable up to at least 36 h of growth. Even 
after 96 h a significantly higher level of Pr-CoA could be 
detected in ANG5 expressing pccB/accA1 than in ANG4 
expressing ssfE (Fig. 3c).
Further analyses of the angelyl‑CoA pathway in yeast
In order to investigate the individual functions of the ssf 
genes involved in AN-CoA biosynthesis in  vivo, three 
truncated pathways were assembled on plasmids and 
transformed into yeast (strains ANG6-ANG8). The three 
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strains expressed prpE together with one (ssfE, ANG6), 
two (ssfE/ssfN, ANG7), or three (ssfE/ssfN/ssfK, ANG8) 
genes from the ssf pathway. These strains were analysed 
together with the control strain expressing solely prpE 
(ANG9), and the strain expressing the entire pathway 
(prpE + ssfE/ssfN/ssfK/ssfJ, ANG4). Strains were analysed 
for production of Pr-CoA, AN-CoA and the putative 
intermediates MM-CoA, MAA-CoA and HMB-CoA (see 
Additional file  1: Figure S2 for extracted ion chromato-
grams of all strains).
The strain expressing solely prpE (ANG9) accumulated 
only Pr-CoA (Fig.  4). The same is true for ANG6 (prpE 
and ssfE expressed). Neither MM-CoA nor MAA-CoA 
could be detected in strains expressing prpE/ssfE/ssfN 
(ANG7). However, accumulation of Pr-CoA in those 
strains was much lower compared to control strain 
Fig. 2 Intracellular accumulation of Pr-CoA and AN-CoA in S. cerevisiae strains expressing the ssfENKJ genes. a Graphical representation of the 
pathway starting with propionic acid feeding. b Pr-CoA accumulation in strains expressing ssfENKJ, and ssfENKJ together with prpE, shown as fold 
change compared to the respective control strains. Engineered strains were incubated in selective SC medium either non supplemented (“non 
fed”) or supplemented with 0.5 g/L propionic acid (“+ propionate”). c Intracellular accumulation of AN-CoA in strains ANG3 (ssfENKJ) and in strain 
ANG4 (prpE + ssfENKJ) grown for 72 h in SC medium supplemented with 0.5 g/L propionic acid. The medium was buffered to pH 4.5 (yellow bars) 
or supplied unbuffered (green bars). Circles indicate  OD600 at 72 h of growth. Represented are the averages and standard deviations of three 
independent cultures
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ANG9, suggesting that Pr-CoA might have been utilized 
for further reactions inside the cells. When the pathway 
was extended to include ssfK (ANG8) yeasts produced 
HMB-CoA. In addition, a substantial accumulation of 
MM-CoA (1.7 mg/L) was detected in this strain, together 
with higher levels of Pr-CoA, compared to strains ANG6 
or ANG7 (nearly seven- and ninefold more, respec-
tively). Finally, strain ANG4, containing the entire path-
way, accumulated AN-CoA together with lower amounts 
of HMB-CoA (nearly twofold less than ANG8) and 
MM-CoA (7.5-fold less than ANG11). Pr-CoA levels 
were comparable to those found in the control strain 
expressing only prpE (Fig.  4). Over time accumulation 
of HMB-CoA in strains expressing prpE/ssfE/ssfN/ssfK 
and accumulation of AN-CoA in strains expressing prpE/
ssfE/ssfN/ssfK/ssfJ was accompanied by a decrease of the 
earlier intermediates (Additional file 1: Figure S3).
Angelyl‑CoA production in yeast starting 
from methyl‑malonate
As an alternative route to AN-CoA production, we 
evaluated the malonyl/methylmalonyl-CoA ligase oper-
ating naturally in Streptomyces coelicolor. The biosyn-
thetic route should allow for MM-CoA synthesis in 
yeast upon methyl-malonate supplementation and het-
erologous expression of malonyl-CoA synthase matB 
(Fig. 5a). MatB is an enzyme exhibiting a certain prom-
iscuity, accepting both malonate and methyl-malonate 
as substrates [23]. Building of this pathway may avoid 
accumulation of potentially toxic amounts of Pr-CoA 
as it starts with a different substrate for production of 
methyl-malonyl-CoA.
Three plasmids were constructed and transformed into 
yeast, thus generating strain ANG10 (expressing matB), 
strain ANG11 (expressing ssfN/ssfK/ssfJ) and strain 
ANG12 (expressing the entire pathway matB + ssfN/ssfK/
ssfJ). Without feeding of methyl-malonic acid MM-CoA 
could not be detected in those strains (data not shown). 
Upon methyl-malonate feeding, expression of matB in 
strain ANG10 led to around 2.7  mg/L MM-CoA accu-
mulation, representing the majority of the acyl CoA-pool 
(Fig. 5b). As expected, none of the compounds of inter-
est could be detected in strain ANG7 expressing exclu-
sively the ssfN/ssfK/ssfJ genes. Strain ANG12, expressing 
the entire pathway (matB + ssfN/ssfK/ssfJ), was able to 
produce not only MM-CoA but also AN-CoA in titres 
in the range of 1.3–1.9  mg/L (Fig.  5b, c). Interestingly, 
also Pr-CoA substantially accumulated in strain ANG12 
(matB + ssfN/ssfK/ssfJ) (Fig.  5b). This was not observed 
in strain ANG10 or ANG11, suggesting that the accu-
mulation was induced only when the full pathway was 
expressed. As shown with propionic acid feeding of 
strains ANG4 and ANG5 (Fig.  3a, b), AN-CoA accu-
mulation peaked at 12  h of growth and declined there-
after to levels close to the limit of detection (Fig.  5c). 
MM-CoA accumulated in this strain to maximal titres of 
6.1 ± 0.1 mg/L at 12 h.
Fig. 3 Time course of production of AN-CoA, Ac-CoA and Pr-CoA. a 
Ac-CoA and AN-CoA produced by strain expressing prpE + ssfENKJ 
(ANG4). b Ac-CoA and AN-CoA produced by strain expressing 
prpE + pccB/accA1 + ssfNKJ (ANG5). c Relative amounts of Pr-CoA 
in strains expressing prpE + ssfENKJ (ANG4) and strains expressing 
prpE + pccB/accA1 + ssfNKJ (ANG5). Strains were grown in SC medium 
supplemented with 0.5 g/L propionic acid and buffered to pH 4.5. 
Filled circles in a, b indicate  OD600. Represented are the averages and 
standard deviations of three independent cultures
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Angelic acid feeding and angelyl‑CoA production
In addition to setting up the entire pathway for ange-
lyl-CoA production in yeast, we attempted to produce 
AN-CoA directly from angelic acid. We grew yeast 
strains expressing heterologous acyl-CoA ligases from 
plant, bacterial and fungal origin in angelic acid-supple-
mented medium (schematically shown in Fig. 6a). Acyl-
CoA ligases can catalyze acyl-CoA thioester formation 
through adenylation of the carboxylic acid substrate. 
Many studies have explored the substrate specificity of 
these enzymes, revealing in several cases remarkable 
substrate promiscuities beyond their canonical substrate 
pools [24–26].
In preliminary experiments we found that two of the 
CoA-ligases tested showed the ability to accept angelic 
acid as a substrate for thio-esterification: carboxyl CoA 
ligase 4 from Humulus lupulus (HlCCL4) and predicted 
acyl-activating enzyme 6 from Solanum tuberosum 
(StCCL). The sequences of those two CoA ligases were 
used to search for CoA ligases in the available tran-
scriptome of Euphorbia peplus, the plant producing 
ingenol-3-angelate. We identified several potential can-
didates. Three of them, arbitrarily named EpCCL1, 
EpCCL2 and EpCCL3, were prioritized based on their 
high sequence identity to HlCCL4 and StCCL (Addi-
tional file 1: Figure S4).
Three individual strains were constructed express-
ing the codon-optimized variants of EpCCL1 (ANG16), 
EpCCL2 (ANG17) or EpCCL3 (ANG18). Strains ANG16, 
ANG17, and ANG18, in parallel with strains expressing 
HlCCL4 (ANG14) and StCCL (ANG15), were assayed for 
AN-CoA production using medium supplemented with 
0.1 g/L angelic acid. Figure 6b shows the relative activity 
of the CCL enzymes in yeast, expressed as percentage of 
AN-CoA accumulating in those cells. All of the putative 
CoA-ligases showed activity against angelic acid. Yeasts 
expressing the CoA ligase from S. tuberosum (ANG15) 
accumulated the highest amount of AN-CoA after 24 h. 
The amount of AN-CoA accumulating in those cells was 
set to 100%. ANG14, the strain expressing HlCCL4, accu-
mulated 75% of this amount of AN-CoA, whereas yeasts 
expressing EpCCL1 (ANG16) or EpCCL2 (ANG17) 
Fig. 4 Intracellular accumulation of Pr-CoA, MM-CoA, HMB-CoA, AN-CoA in strains expressing parts of the AN-CoA pathway. MAA-CoA could 
not be found in any of the strains. Pr-CoA (purple bars), MM-CoA (yellow bars), HMB-CoA (red bars) and AN-CoA (green bars) in strains expressing 
prpE (ANG9), prpE + ssfE (ANG6), prpE + ssfE/ssfN (ANG7), prpE + ssfE/ssfN/ssfK (ANG8) and prpE + ssfE/ssfN/ssfK/ssfJ (ANG4). Engineered strains were 
incubated for 12 h in selective SC medium buffered to pH 4.5 and supplemented with 0.5 g/L propionic acid. Represented are the averages and 
standard deviations of three independent cultures
Fig. 5 Impact of methyl-malonic acid feeding on AN-CoA production. a Graphical representation of the pathway starting with methyl-malonic acid 
feeding. b Intracellular accumulation of Ac-CoA (orange bars), Pr-CoA (purple bars), MM-CoA (yellow bars), HMB-CoA (red bars) and AN-CoA (green 
bars) in strains expressing matB (ANG10), ssfNKJ (ANG11) and matB + ssfNKJ (ANG12), upon 12 h of growth. c Time course of production of AN-CoA 
(open squares), MM-CoA (open circles) and Ac-CoA (filled triangles) in strain expressing matB + ssfNKJ (ANG12), and corresponding optical density 
at 600 nm (filled circles). All engineered strains were incubated in selective SC medium, supplemented with 0.5 g/L methyl-malonic acid (all data: 
mean ± SD, n = 3)
(See figure on next page.)
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accumulated 56 or 62% of this amount of AN-CoA, 
respectively. The strain expressing EpCCL3 accumu-
lated marginal amounts of AN-CoA (7% of the amount 
of ANG15). Expression of the heterologous enzymes had 
negligible effect on strain growth (data not shown).
Time course analysis of the StCCL expressing strain 
revealed a peak in AN-CoA production after 12  h, fol-
lowed by a net decrease in titre (Fig. 6c). These kinetics 
were similar to the ones described before for AN-CoA 
production in yeast expressing the bacterial ssf pathway. 
The highest production level of AN-CoA at 12 h of batch 
culture was 39.0 ± 9.9 mg/L.
Discussion
In this study we demonstrated the potential of yeast to 
produce AN-CoA by (A) heterologous expression of 
genes from a recently discovered gene cluster derived 
from actinomycetes, (B) the heterologous expression of 
plant acyl-CoA synthases able to accept angelic acid as 
substrate.
Expression of the ssf pathway in S. cerevisiae
First, we showed production of AN-CoA in yeast through 
expression of part of the ssf pathway adopted from Strep-
tomyces sp. SF2575. Pr-CoA is converted by SsfE to 
MM-CoA, which serves as substrate for the subsequent 
condensation reaction with Ac-CoA. Pr-CoA and Ac-
CoA are both present in yeast, albeit the former only in 
small amounts. Upon propionate supplementation, ten 
times more AN-CoA (almost 5  mg/L) was produced in 
buffered medium when expressing an additional heter-
ologous CoA-ligase, specific for Pr-CoA (propionyl-CoA 
synthase from Salmonella, PrpE).
Interestingly, the intracellular Pr-CoA concentration 
reached high levels, even when a second copy of the ssfE 
gene was expressed (Additional file  1: Figure S5). This 
doubling of the gene dosage should optimize coupling 
of Pr-CoA synthesis and the further downstream steps, 
pulling most of the Pr-CoA to AN-CoA. We propose 
that Pot1, the only 3-ketoacyl-CoA thiolase present in 
S. cerevisiae, may be responsible for Pr-CoA accumula-
tion through the breakdown of the AN-CoA pathway 
intermediate MAA-CoA. Pot1 is normally involved in 
β-oxidation and it catalyses the conversion of 3-ketoacyl-
CoA into an acyl-CoA shortened by two carbon atoms 
[27]. Shortening of MAA-CoA by two carbon atoms may 
inevitably lead to generation of Pr-CoA and Ac-CoA, 
thus explaining Pr-CoA build-up. The accumulation of 
Pr-CoA, besides being responsible for loss of carbon flux 
towards AN-CoA, may also be responsible for the growth 
inhibition suffered by those strains. Strains expressing 
ssfE reached  OD600 values of ~ 7 after 96  h of growth, 
whereas strains expressing the pccB/accA1 complex, 
Fig. 6 AN-CoA production in strains expressing plant acyl-CoA 
ligases and fed with angelic acid. a Angelate enters the cell and is 
converted to angelyl-CoA by carboxyl CoA ligases. b Relative amount 
of AN-CoA accumulating in yeast strains expressing CoA-ligases 
HlCCL4 (ANG14), StCCL (ANG15), EpCCL1 (ANG16), EpCCL2 (ANG17), 
and EpCCL3 (ANG18). Strains were cultured in selective SC medium 
supplemented with 0.1 g/L angelic acid. c Time course of production 
of AN-CoA (open squares) and Ac-CoA (open triangles) by the strain 
expressing CoA-ligase StCCL (ANG15). The corresponding  OD600 
values are represented by filled circles. Engineered strains were 
incubated in selective SC medium supplemented with 0.1 g/L angelic 
acid (all data: mean ± SD, n = 3)
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instead of ssfE, underwent a more severe growth inhibi-
tion  (OD600 = 3 after 96 h), parallel to the elevated accu-
mulation of Pr-CoA (Fig. 3a, b). It has been described for 
both the filamentous fungus Aspergillus nidulans and the 
bacterium Rhodobacter sphaeroides that Pr-CoA inhibits 
enzymes involved in glucose metabolism, in particular 
CoA-dependent enzymes such as pyruvate dehydroge-
nase and succinyl-CoA synthase, leading to a significant 
growth retardation [28, 29]. In Escherichia coli, Pr-CoA 
was found to be a competitive inhibitor of citrate syn-
thase [30]. Similar mechanisms could explain the severe 
growth retardation observed in yeast upon accumulation 
of Pr-CoA.
We attempted to overcome Pr-CoA toxicity by employ-
ing an alternative biosynthetic route that directly 
produced MM-CoA upon expression of methyl-malonyl-
CoA synthase matB from Streptomyces coelicolor. This 
enzyme has recently been shown to generate methyl-
malonyl-CoA in yeast upon methyl-malonate feeding 
[19]. Combining matB with the ssf pathway genes indeed 
induced generation of AN-CoA without severely ham-
pering cell growth. Cells grown in those conditions could 
reach an  OD600 of 10.7 after 96 h of growth, compared to 
 OD600 of 3 and 7 when supplementing propionic acid (see 
Figs. 3, 5). Nevertheless, the levels of AN-CoA (1.5 mg/L) 
did not reach the values seen in yeast operating with the 
Pr-CoA pathway. The fact that expression of this alter-
native pathway also induces accumulation of Pr-CoA is 
consistent with the previously formulated hypothesis 
that Pr-CoA accumulation is induced via Pot1 activity on 
MAA-CoA.
The individual steps of the pathway were further char-
acterized in  vivo by sequential expression of the corre-
sponding pathway genes. Contrary to expectations, no 
MM-CoA nor MAA-CoA could be detected in strains 
expressing either only ssfE, or ssfE together with ssfN. In 
cells expressing the entire pathway, accumulation of MM-
CoA was observed—probably as a result of a “pulling 
effect” which led to substrate saturation of SsfN. MAA-
CoA was never detected in any of the strains, even not in 
early phases of yeast growth, as confirmed by acyl-CoA 
analysis at 4 and 8 h (Additional file 1: Figure S3). MAA-
CoA was also not detected in yeasts expressing genes 
from the thg cluster of P. rubra (Additional file 1: Figure 
S6), albeit the yeasts were able to produce AN-CoA. The 
activities of the enzymes ThgI, ThgK and ThgH, homo-
logues to SsfN, SsfK and SsfJ, were characterized in vitro 
by Inahashi et al. [14], confirming that the AN-CoA path-
way starts via MM-CoA and Ac-CoA condensation and 
runs through the intermediates MAA-CoA and HMB-
CoA. Rapid conversion of MAA-CoA to either HMB-
CoA or Pr-CoA and Ac-CoA (see before) might explain 
its analytical absence.
We have demonstrated production of AN-CoA up to 
6.4  mg/L in yeast by introducing the bacterial ssf path-
way. However, avenues remain to explore for further 
optimization of S. cerevisiae-based production of AN-
CoA. Titres may e.g. be improved by insertion of higher 
copy numbers of rate limiting pathway enzymes, by pro-
moter-based optimization of expression levels of indi-
vidual enzymes, or by avoiding accumulation of pathway 
intermediates. Deletion of the non-essential gene pot1 
could also increase production levels. Compartmentali-
zation of the heterologous pathway may also be a valu-
able approach for efficient production as it may increase 
spatial proximity of enzymes involved. To avoid feeding 
of propionic acid, insertion of a de novo production route 
to Pr-CoA is desirable. During submission of this man-
uscript, Krink-Koutsoubelis and colleagues reported a 
direct Pr-CoA production route from malonyl-CoA using 
parts of the 3-hydroxypropionate carbon assimilation 
cycle found in certain auxotrophic archaea and bacteria 
[31]. Coupling of this Pr-CoA biosynthesis pathway to 
the ssf pathway could enable AN-CoA production with-
out addition of media supplements.
Saccharomyces cerevisiae has already been used for the 
biosynthesis of important precursors of esters of angelic 
acid, such as precursors of the diterpenoid ingenol-3-an-
gelate [32]. Together with the reported AN-CoA synthe-
sis, S. cerevisiae may provide an important and economic 
route to total biosynthesis of ingenol-3-angelate and 
other valuable angelates.
Expression of acyl‑CoA synthases from plant origin in S. 
cerevisiae
We also report the identification of plant acyl-CoA 
synthases able to utilize angelic acid in order to yield 
AN-CoA. In plants AN-CoA production most prob-
ably follows a different pathway than the one found in 
actinomycetes. AN-CoA may be derived from degrada-
tion of l-isoleucine (via 3-methyl-2-oxopentanoate and 
2-methylbutanoyl-CoA) or from tiglyl-CoA through a 
cis–trans isomerase system, similar to that responsible 
for crotonyl-CoA isomerization [33, 34]. However, none 
of the responsible enzymes for its biosynthesis have been 
identified.
Here we attempted to enable ligation of angelic acid 
and CoA by employing heterologous enzymes known to 
have CoA ligation activity and substrate promiscuity. The 
enzyme HlCCL4 from H. lupulus, involved in bitter acids 
biosynthesis pathway in hop, was shown to have sub-
strate preference towards several short-chain fatty acids, 
including isobutyric acid and 2-methylbutyric acid [35]. 
Obviously, the ability of HlCCL4 to utilize angelic acid 
as substrate can be attributed to the structural resem-
blance of the saturated acids that are the usual preferred 
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substrates of the enzyme. The enzyme StCCL, showing 
71% identity to HlCCL4 (Additional file  1: Figure S4), 
showed the highest activity and led to the highest titres of 
AN-CoA. Two of the enzymes identified in the transcrip-
tome of Euphorbia peplus (EpCCL1 and EpCCL2) proved 
to be quite efficient in AN-CoA production, but not as 
much as StCCL. The Euphorbia CoA ligases are probably 
tightly linked to ingenol biosynthesis in the plant. There-
fore, activity of those enzymes is synchronized with inge-
nol-3-angelate biosynthesis rather than being optimized 
for AN-CoA production. It may be also possible that AN-
CoA synthesis does not go via the intermediate angelic 
acid in Euphorbia peplus.
Although angelic acid feeding might not be a relevant 
strategy for biotechnological production of AN-CoA, 
we envision that the strains expressing the CoA ligases 
identified in this work can provide a system for screening 
and functional characterization of acyl-transferases able 
to use angelyl-CoA as donor acyl-CoA. Such enzymes 
are needed for the transfer of the angelate moiety onto 
diverse acceptor molecules. More work will be necessary 
to identify these enzymes. We are currently screening the 
transcriptome of Euphorbia peplus for identification of 
possible candidates involved in ingenol-3-angelate bio-
synthesis. Candidates for this reaction are enzymes of the 
BAHD family of acyltransferases, as it has been recently 
shown for the esterification of hydroxycinnamoyl- and 
benzoyl-CoA [36]. Rapid acylation by BAHDs would 
probably also prevent the observed disappearance of 
angelyl-CoA, which may be due to intracellular hydroly-
sis of the activated compound, as previously observed for 
several CoA-activated molecules [37, 38].
Conclusions
In this proof of concept study we have successfully 
achieved AN-CoA production in yeast by the expression 
of genes from the bacterial ssf cluster. This represents 
the first report on the activity of these enzymes in vivo. 
Moreover, we have identified acyl-CoA ligases from dif-
ferent plant species that use angelic acid as substrate and 
yield considerable titres of AN-CoA. Our results pave the 
way for future microbial production of different kinds of 
angelates.
Methods
Chemicals and media
All chemicals were bought from Sigma-Aldrich (St. Louis 
Missouri, USA) unless stated otherwise. Authentic stand-
ard of angelyl-CoA was synthesized by Jubilant LifeS-
ciences, India.
LB medium for growth of Escherichia coli was supplied 
from Carl Roth GmbH + Co. KG (Karlsruhe, Germany), 
and was supplemented with 100  μg/L of ampicillin for 
amplification of plasmids.
Yeast extract peptone dextrose (YPD) medium with 
20  g/L glucose was used for growth of wildtype strains 
prior to transformation. For pre- and main cultures of 
transformed strains we used synthetic complete (SC) 
drop-out medium (Formedium LTD, Hustanton, Eng-
land), supplemented with 6.7  g/L yeast nitrogen base, 
20 g/L glucose and all amino acids necessary for the cor-
responding auxotrophy. For propionyl-CoA carboxy-
lase-expressing strains medium was supplemented with 
additional biotin (20  μg/L). Basic amounts of biotin are 
routinely added to baker’s yeast cultures as the co-factor 
is not produced by the laboratory strain S288C [39].
For preparation of pH 4.5-buffered medium a 1.0  M 
stock solution of citrate buffer (sodium citrate and citric 
acid) was prepared. Buffer stocks were filter-sterilized 
and used at the final concentration of 100 mM.
Organic acid supplemented media were prepared 
as solutions containing 0.5  g/L (6.7  mM) propionic 
acid, 0.5  g/L (4.23  mM) methylmalonic acid, or 0.1  g/L 
(1.0  mM) angelic acid, respectively. Stock solutions 
(1.0  M) of methyl-malonic acid and angelic acid were 
prepared in deionized water and ethanol respectively.
Plasmids and strains
Table  1 lists all plasmids constructed in this work. All 
coding sequences were synthesized by  GeneArt® (Ther-
mofisher Scientific, Zug, Switzerland) as yeast-codon 
optimized versions. Standard cloning was done using the 
restriction enzymes HindIII HF and SacII, and T4 DNA 
ligase from New England Biolabs (Ipswich, Massachu-
setts, USA) according to standard protocols [40]. E. coli 
XL10 Gold (Agilent, Santa Clara, California, USA) cells 
were used for subcloning of genes. Coding sequences 
were cloned in single expression vectors (ARS/CEN), 
or in entry vectors for assembly of multigene expres-
sion plasmids in  vivo by homologous recombination 
(HRTs), as described by Eichenberger et al. [41]. Briefly, 
genes were cloned into entry vectors, carrying different 
combinations of promoters and terminators (“expres-
sion cassettes”), flanked by 60 base pair homology 
sequences. Helper cassettes containing (a) the autono-
mously replicating sequence, (b) a centromere region, 
and (c) the auxotrophy marker are also flanked by 60 base 
pair homology sequences. Expression cassettes as well 
as helper cassettes were released by one-pot digestions 
using AscI (New England Biolabs). The digested mixtures 
were transformed into yeast. In case of negative expres-
sion control, corresponding empty entry vectors were 
added to the digestion mix.
Saccharomyces cerevisiae strains generated throughout 
this study are listed in Table  2. All constructed strains 
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were derived from strain NCYC 3608 (NCYC, Norwich, 
United Kingdom), a derivative of S288C, modified in our 
labs to add auxotrophophic markers (HIS, LEU, URA), 
and repair the petite phenotype according to Dimitrov 
et al. [42]. All yeast strains were stored in 25% glycerol at 
− 80 °C.
Table 1 List of genes used in this work and plasmids they were cloned into
Plasmid Promoter and gene Plasmid type Organism Accession number
pANG1 pPGK1-ssfN Entry vector Streptomyces sp. SF2575 ADE34503.1
pANG2 pTEF1-ssfK Entry vector Streptomyces sp. SF2575 ADE34504.1
pANG3 pPDC1-ssfJ Entry vector Streptomyces sp. SF2575 ADE34505.1
pANG4 pGPD1-ssfE Entry vector Streptomyces sp. SF2575 ADE34513.1
pANG5 pTEF1-thgK Entry vector Polymorphospora rubra K07–0510 BAU79605.1
pANG6 pPDC1-thgH Entry vector Polymorphospora rubra K07–0510 BAU79602.1
pANG7 pTEF2-thgI Entry vector Polymorphospora rubra K07–0510 BAU79603.1
pANG8 pGPD1-pccB Entry vector Streptomyces coelicolor A3(2) NP_629079.1
pANG9 pPGK1-accA1 Entry vector Streptomyces coelicolor A3(2) NP_733754.1
pANG10 pPGK1-matB ARS/CEN Streptomyces coelicolor CAB86109.1
pANG11 pPGK1-prpE ARS/CEN Salmonella enterica serovar Typhimurium AAC44817.2
pANG12 pGPD1-ssfE ARS/CEN Streptomyces sp. SF2575 ADE34513.1
pANG13 pCYC1- prpE ARS/CEN Salmonella enterica serovar Typhimurium AAC44817.2
pANG14 pTEF1-HlCCL4 ARS/CEN Humulus lupulus AGA17921.1
pANG15 pTEF1-StCCL ARS/CEN Solanum tuberosum XP_006350454.1
pANG16 pTEF1-EpCCL1 ARS/CEN Euphorbia peplus –
pANG17 pTEF1-EpCCL2 ARS/CEN Euphorbia peplus –
pANG18 pTEF1-EpCCL3 ARS/CEN Euphorbia peplus –
Table 2 List of strains constructed in this work
Strains Description
ANG1 Control strain with empty plasmid (URA3)
ANG2 Contains expression cassettes of ssfE/ssfN/ssfK/ssfJ (URA3)
ANG3 Contains expression cassettes of ssfE/ssfN/ssfK/ssfJ (URA3) and an empty plasmid (LEU2)
ANG4 Contains expression cassettes of ssfE/ssfN/ssfK/ssfJ (URA3) and prpE (LEU2)
ANG5 Contains expression cassettes of pccB/accA1/ssfN/ssfK/ssfJ (URA3) and prpE (LEU2)
ANG6 Contains expression cassettes of ssfE (URA3) and prpE (LEU2)
ANG7 Contains expression cassettes of ssfE/ssfN (URA3) and prpE (LEU2)
ANG8 Contains expression cassettes of ssfE/ssfN/ssfK and prpE (LEU2)
ANG9 Contains expression cassettes of prpE (LEU2) and an empty plasmid (URA3)
ANG10 Contains expression cassettes of matB (LEU2) and an empty plasmid (URA3)
ANG11 Contains expression cassettes of ssfN/ssfK/ssfJ (URA3) and an empty plasmid (LEU2)
ANG12 Contains expression cassettes of ssfN/ssfK/ssfJ (URA3) and matB (LEU2)
ANG13 Contains expression cassettes of ssfE/thgK/thgH/thgI (URA3) and prpE (LEU2)
ANG14 Contains expression cassette of CoA ligase from Humulus lupulus (LEU2)
ANG15 Contains expression cassette of CoA ligase from Solanum tuberosum (LEU2)
ANG16 Contains expression cassette of CoA ligase-1 from Euphorbia peplus (LEU2)
ANG17 Contains expression cassette of CoA ligase-2 from Euphorbia peplus (LEU2)
ANG18 Contains expression cassette of CoA ligase-3 from Euphorbia peplus (LEU2)
ANG19 Control strain with empty plasmid (LEU2)
ANG20 Contains expression cassettes of ssfE/ssfN/ssfK/ssfJ (URA3), prpE (LEU2) and an empty plasmid (HIS3)
ANG21 Contains expression cassettes of ssfE/ssfN/ssfK/ssfJ (URA3), prpE (LEU2) and an additional copy of ssfE (HIS3)
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Yeast transformation and growth
Yeast transformation was performed using the lithium 
acetate method [43]. Transformants were grown on agar 
plates prepared with selective SC drop-out medium. Pre-
cultures were grown for 24 h at 30 °C on an orbital shaker 
(160  rpm). Optical density at 600  nm  (OD600) of a 1:40 
dilution was measured in an Ultrospec 10 table top spec-
trophotometer (GE Healthcare, Little Chalfont, United 
Kingdom). Main cultures for production of angelyl-CoA 
were inoculated in 25 mL of medium at a starting  OD600 
of 0.1, and grown at 30 °C (160 rpm) for 12–96 h. Media 
supplemented with organic acids were used exclusively 
for the growth of main cultures.
Sample preparation
We harvested 100 OD-units (~ 1 × 109 cells) by centrifu-
gation at 4000  rpm for 5  min. Cell pellets were re-sus-
pended in 1 mL of water and re-pelleted in 2 mL screw 
cap tubes. Extraction from pellets was performed as 
described previously [44]. Briefly, cell pellets were re-sus-
pended in 500 μL of 75% ethanol and shaken (1500 rpm) 
for 3  min at 95  °C in a Thermo-Shaker TS-100 (Axon-
lab, Reichenbach an der Fils, Germany). Cell debris was 
removed by centrifugation (4000  rpm, 5  min) and the 
liquid phase was transferred to a 96 deepwell microplate. 
The ethanol extracts were evaporated for 5  h at 35  °C 
using a Genevac HT4 (SP Industries 935 Mearns Road-
Warminster, PA18974). Dried pellets were re-solubilized 
in 100 μL of 50  mM ammonium acetate. Remaining 
debris was removed by centrifugation (5  min at 4000g), 
and supernatants were used for analyses.
Acyl‑CoAs analysis
Analytical LC–MS was carried out using a Waters Xevo 
G2 XS TOF mass detector (Milford, Massachusetts, 
USA). Separation of the compounds was achieved on a 
Waters Acquity  UPLC® HSS T3 C18 column (1.7  μm, 
2.1  mm × 50  mm) kept at 50  °C. Mobile phases were 
composed of (A) 1% acetonitrile, 99% water, 5  mM 
ammonium acetate, and (B) 10% acetonitrile, 90% iso-
propanol, 5 mM ammonium acetate. An elution gradi-
ent from 99% A to 0% A within 2 min at a flow rate of 
0.5 mL/min was used. The mass analyzer was equipped 
with an electrospray source and operated in negative 
mode. Capillary voltage was 1.0  kV; the source was 
kept at 150  °C and the desolvation temperature was 
500  °C. Desolvation and cone gas flow were 1000 and 
150  L/h, respectively. For each compound of interest 
we calculated peak areas on the extracted ion chro-
matograms of the respective [M−H]− ions, using a 
mass window of 0.02  Da. Angelyl-CoA, acetyl-CoA 
and methyl-malonyl-CoA were quantified using a lin-
ear calibration curve with authentic standards ranging 
from 0.03125 to 4  mg/L for all compounds. For other 
compounds without standards, Area-under-the-curve 
(AUC) values were calculated for a relative quantity of 
the compound. Concentration and AUC values were 
normalized per 100 OD units.
Abbreviations
KAS III: beta-ketoacyl-(acyl-carrier-protein) synthase III; ACP: acyl-carrier-
protein; AN-CoA: angelyl-CoA; Ac-CoA: acetyl-CoA; MM-CoA: methyl-
malonyl-CoA; MAA-CoA: methyl-acetoacetyl-CoA; HMB-CoA: 3-hydroxyl-
2-methyl-butyryl-CoA; Pr-CoA: propionyl-CoA; CCL: carboxyl CoA ligase; 
HlCCL4: carboxyl CoA ligase 4 from Humulus lupulus; StCCL: acyl-activating 
enzyme 6 from Solanum tuberosum; EpCCL1: CoA-ligase 1 from Euphorbia 
peplus; EpCCL2: CoA-ligase 2 from Euphorbia peplus; EpCCL3: CoA-ligase 3 
from Euphorbia peplus; BAHD: BEAT (benzoyl alcohol O-acetyltransferase), 
AHCT (anthocyanin O-hydroxycinnamoyl transferase), HCBT (anthranilate 
N-hydroxycinnamoyl/benzoyl transferase), and DAT (deacetyl vindoline 
4-O-acetyltransferase).
Authors’ contributions
RC carried out strain constructions, experiments, extractions, and drafted the 
manuscript. DF established the analysis methods and analysed all samples. 
NW performed initial studies for the synthesis of AN-CoA and constructed 
some of the strains and plasmids. RC, HH and NW designed and coordinated 
the study. HH and NW reviewed and edited the manuscript. All authors read 
and approved the final manuscript.
Author details
1 Evolva SA, Duggingerstrasse 23, 4153 Reinach, Switzerland. 2 Department 
of Plant and Environmental Sciences, University of Copenhagen, 1871 Fred-
eriksberg C, Denmark. 
Acknowledgements
We thank Samantha Capewell for proofreading of the manuscript, Andreas 
Dallügge and Curt Nielsen for providing the genes encoding HlCCL4 and 
StCCL, Philipp Berninger for support in bioinformatics and Professor Birger 
Lindberg Møller for support.
Competing interests
Roberta Callari, Harald Heider and Nora Weber declare financial competing 
interests in the form of a pending patent application filed by Evolva.
Availability of data and materials
The datasets used and/or analyzed during the current study are available from 
the corresponding author on reasonable request.
Consent for publication
Not applicable.
Ethics approval and consent to participate
Not applicable.
Funding
This work was supported by “Plant Power: Light-driven synthesis of complex 
terpenoids using cytochrome P450s” (12-131834) funded by the Danish 
Innovation Foundation (project lead, Dr. Poul Erik Jensen, University of Copen-
hagen, Department of Plant and Environmental Sciences, Plant Biochemistry 
Laboratory).
Additional file
Additional file 1. Additional figures and table.
Page 13 of 14Callari et al. Microb Cell Fact  (2018) 17:72 
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub-
lished maps and institutional affiliations.
Received: 11 January 2018   Accepted: 7 May 2018
References
 1. Weedon D, Chick J. Home treatment of basal cell carcinoma. Med J Aust. 
1976;1:928.
 2. Aydın AA, Zerbes V, Parlar H, Letzel T. The medical plant butterbur 
(Petasites): analytical and physiological (re)view. J Pharm Biomed Anal. 
2013;75:220–9.
 3. Fu H-Z, Li C-J, Yang J-Z, Shen Z-F, Zhang D-M. Potential anti-inflam-
matory constituents of the stems of Gordonia chrysandra. J Nat Prod. 
2011;74:1066–72.
 4. Zhang J, Li L, Jiang C, Xing C, Kim S-H, Lü J. Anti-cancer and other bioac-
tivities of Korean Angelica gigas Nakai (AGN) and its major pyranocou-
marin compounds. Anticancer Agents Med Chem. 2012;12:1239–54.
 5. Andersen TB, López CQ, Manczak T, Martinez K, Simonsen HT. Thapsigar-
gin—from Thapsia L. to mipsagargin. Molecules. 2015;20:6113–27.
 6. Pickens LB, Kim W, Wang P, Zhou H, Watanabe K, Gomi S, et al. Biochemi-
cal analysis of the biosynthetic pathway of an anticancer tetracycline 
SF2575. J Am Chem Soc. 2009;131:17677–89.
 7. Hatsu M, Sasaki T, Watabe H, Miyadoh S, Nagasawa M, Shomura T, et al. 
A new tetracycline antibiotic with antitumor activity. I. Taxonomy and 
fermentation of the producing strain, isolation and characterization of 
SF2575. J Antibiot. 1992;45:320–4.
 8. Nakashima T, Okuyama R, Kamiya Y, Matsumoto A, Iwatsuki M, Inahashi Y, 
et al. Trehangelins A, B and C, novel photo-oxidative hemolysis inhibitors 
produced by an endophytic actinomycete, Polymorphospora rubra K07-
0510. J Antibiot. 2013;66:311–7.
 9. Ball M, Andrews SP, Wierschem F, Cleator E, Smith MD, Ley SV. Total 
synthesis of thapsigargin, a potent SERCA pump inhibitor. Toyoshima, C.; 
Nomura, H. Nature. 2002;418:605.
 10. Liang X, Grue-Sørensen G, Petersen AK, Högberg T. Semisynthesis of 
ingenol 3-angelate (PEP005): efficient stereoconservative angeloylation 
of alcohols. Synlett© Georg Thieme Verlag. 2012;23:2647–52.
 11. Harel D, Khalid SA, Kaiser M, Brun R, Wünsch B, Schmidt TJ. Encecalol 
angelate, an unstable chromene from Ageratum conyzoides L.: total syn-
thesis and investigation of its antiprotozoal activity. J Ethnopharmacol. 
2011;137:620–5.
 12. Jørgensen L, McKerrall SJ, Kuttruff CA, Ungeheuer F, Felding J, Baran 
PS. 14-Step synthesis of (+)-ingenol from (+)-3-carene. Science. 
2013;341:878–82.
 13. Hohmann J, Evanics F, Berta L, Bartók T. Diterpenoids from Euphorbia 
peplus. Planta Med. 2000;66:291–4.
 14. Inahashi Y, Shiraishi T, Palm K, Takahashi Y, Ōmura S, Kuzuyama T, 
et al. Biosynthesis of trehangelin in Polymorphospora rubra K07–0510: 
identification of metabolic pathway to angelyl-CoA. ChemBioChem. 
2016;17:1442–7.
 15. Luttik MA, Kötter P, Salomons FA, van der Klei IJ, van Dijken JP, Pronk 
JT. The Saccharomyces cerevisiae ICL2 gene encodes a mitochondrial 
2-methylisocitrate lyase involved in propionyl-coenzyme A metabolism. J 
Bacteriol. 2000;182:7007–13.
 16. Pronk JT, van Linden-Beuman A, Verduyn C, Alexander Scheffers TW, van 
Dijken JP. Propionate metabolism in Saccharomyces cerevisiae implica-
tions for the metabolon hypothesis. Microbiology. 1994;140(Pt 4):717–22.
 17. van den Berg MA, de Jong-Gubbels P, Kortland CJ, van Dijken JP, Pronk JT, 
Steensma HY. The two acetyl-coenzyme A synthetases of Saccharomyces 
cerevisiae differ with respect to kinetic properties and transcriptional 
regulation. J Biol Chem. 1996;271:28953–9.
 18. Horswill AR, Escalante-Semerena JC. The prpE gene of Salmonella 
typhimurium LT2 encodes propionyl-CoA synthetase. Microbiology. 
1999;145(Pt 6):1381–8.
 19. Mutka SC, Bondi SM, Carney JR, Da Silva NA, Kealey JT. Metabolic pathway 
engineering for complex polyketide biosynthesis in Saccharomyces cerevi-
siae. FEMS Yeast Res. 2006;6:40–7.
 20. Verduyn C, Postma E, Scheffers WA, van Dijken JP. Energetics of Saccharo-
myces cerevisiae in anaerobic glucose-limited chemostat cultures. J Gen 
Microbiol. 1990;136:405–12.
 21. Mira NP, Teixeira MC, Sá-Correia I. Adaptive response and tolerance to 
weak acids in Saccharomyces cerevisiae: a genome-wide view. OMICS. 
2010;14:525–40.
 22. Rodriguez E, Gramajo H. Genetic and biochemical characterization of 
the a and b components of a propionyl-CoA carboxylase complex of 
Streptomyces coelicolor A3(2). Microbiology. 1999;145:3109–19.
 23. An JH, Kim YS. A gene cluster encoding malonyl-CoA decarboxylase 
(MatA), malonyl-CoA synthetase (MatB) and a putative dicarboxylate car-
rier protein (MatC) in Rhizobium trifolii—cloning, sequencing, and expres-
sion of the enzymes in Escherichia coli. Eur J Biochem. 1998;257:395–402.
 24. Pohl NL, Hans M, Lee HY, Kim YS, Cane DE, Khosla C. Remarkably broad 
substrate tolerance of malonyl-CoA synthetase, an enzyme capable 
of intracellular synthesis of polyketide precursors. J Am Chem Soc. 
2001;123:5822–3.
 25. Koryakina I, McArthur J, Randall S, Draelos MM, Musiol EM, Muddi-
man DC, et al. Poly specific trans-acyltransferase machinery revealed 
via engineered Acyl-CoA synthetases. ACS Chem Biol Am Chem Soc. 
2013;8:200–8.
 26. Go MK, Chow JY, Cheung VWN, Lim YP, Yew WS. Establishing a toolkit for 
precursor-directed polyketide biosynthesis: exploring substrate promis-
cuities of acid-CoA ligases. Biochem Am Chem Soc. 2012;51:4568–79.
 27. Hiltunen JK, Mursula AM, Rottensteiner H, Wierenga RK, Kastaniotis AJ, 
Gurvitz A. The biochemistry of peroxisomal beta-oxidation in the yeast 
Saccharomyces cerevisiae. FEMS Microbiol Rev. 2003;27:35–64.
 28. Brock M, Buckel W. On the mechanism of action of the antifungal agent 
propionate. Eur J Biochem Blackwell Sci Ltd. 2004;271:3227–41.
 29. Maruyama K, Kitamura H. Mechanisms of growth inhibition by propion-
ate and restoration of the growth by sodium bicarbonate or acetate in 
Rhodopseudomonas sphaeroides S. J Biochem. 1985;98:819–24.
 30. Man WJ, Li Y, O’Connor CD, Wilton DC. The binding of propionyl-CoA and 
carboxymethyl-CoA to Escherichia coli citrate synthase. Biochim Biophys 
Acta. 1995;1250:69–75.
 31. Krink-Koutsoubelis N, Loechner AC, Lechner A, Link H, Denby CM, Voegeli 
B, et al. Engineered production of short chain acyl-coenzyme A esters in 
S. cerevisiae. ACS Synth Biol. 2018;7:1105–15.
 32. Luo D, Callari R, Hamberger B, Wubshet SG, Nielsen MT, Andersen-
Ranberg J, et al. Oxidation and cyclization of casbene in the biosynthesis 
of Euphorbia factors from mature seeds of Euphorbia lathyris L. Proc Natl 
Acad Sci USA. 2016;113:E5082–9.
 33. Crout DHG. Pyrrolizidine alkaloids. Biosynthesis of the angelate compo-
nent of heliosupine. J Chem Soc R Soc Chem. 1967;0:1233–4.
 34. Mcgaw BA, Woolley JG. The biosynthesis of angelic acid in Cynoglossum 
officinale. Phytochemistry. 1979;18:1647–9.
 35. Xu H, Zhang F, Liu B, Huhman DV, Sumner LW, Dixon RA, et al. Characteri-
zation of the formation of branched short-chain fatty acid:CoAs for bitter 
acid biosynthesis in hop glandular trichomes. Mol Plant. 2013;6:1301–17.
 36. Eudes A, Mouille M, Robinson DS, Benites VT, Wang G, Roux L, et al. 
Exploiting members of the BAHD acyltransferase family to synthesize 
multiple hydroxycinnamate and benzoate conjugates in yeast. Microb 
Cell Fact. 2016;15:198.
 37. Nomura G, Yoshida Y, Takamura Y. Measurement of the intracellular 
concentration of total acyl-CoA extracted by different procedures from 
Gram-negative and Gram-positive bacteria, and yeasts. Agric Biol Chem. 
1988;52:843–4.
 38. Takamura Y, Nomura G. Changes in the intracellular concentration of 
acetyl-CoA and malonyl-CoA in relation to the carbon and energy 
metabolism of Escherichia coli K12. J Gen Microbiol. 1988;134:2249–53.
 39. Bracher JM, de Hulster E, Koster CC, van Broek M, Daran J-MG, van Maris 
AJA, et al. Laboratory evolution of a biotin-requiring Saccharomyces 
cerevisiae strain for full biotin prototrophy and identification of causal 
mutations. Appl Environ Microbiol. 2017;83:e00892-17.
 40. Green MR, Sambrook J. Molecular cloning: a laboratory manual, 4th edn, 
vol. 1 Ch. 9. Cold Spring Harbour Laboratory Press; 2012. p. 157–260.
 41. Eichenberger M, Lehka BJ, Folly C, Fischer D, Martens S, Simón E, et al. 
Metabolic engineering of Saccharomyces cerevisiae for de novo produc-
tion of dihydrochalcones with known antioxidant, antidiabetic, and 
sweet tasting properties. Metab Eng. 2017;39:80–9.
Page 14 of 14Callari et al. Microb Cell Fact  (2018) 17:72 
•
 
fast, convenient online submission
 •
  
thorough peer review by experienced researchers in your field
• 
 
rapid publication on acceptance
• 
 
support for research data, including large and complex data types
•
  
gold Open Access which fosters wider collaboration and increased citations 
 
maximum visibility for your research: over 100M website views per year •
  At BMC, research is always in progress.
Learn more biomedcentral.com/submissions
Ready to submit your research ?  Choose BMC and benefit from: 
 42. Dimitrov LN, Brem RB, Kruglyak L, Gottschling DE. Polymorphisms 
in multiple genes contribute to the spontaneous mitochondrial 
genome instability of Saccharomyces cerevisiae S288C strains. Genetics. 
2009;183:365–83.
 43. Gietz RD, Schiestl RH. High-efficiency yeast transformation using the 
LiAc/SS carrier DNA/PEG method. Nat Protoc. 2007;2:31–4.
 44. Seifar RM, Ras C, Deshmukh AT, Bekers KM, Suarez-Mendez CA, da Cruz 
ALB, et al. Quantitative analysis of intracellular coenzymes in Saccharo-
myces cerevisiae using ion pair reversed phase ultra high performance 
liquid chromatography tandem mass spectrometry. J Chromatogr A. 
2013;1311:115–20.
